Gene Therapy Market Size, Share & Trends Report

Gene Therapy Market (2024 - 2030) Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Route Of Administration, By Region, And Segment Forecasts

Market segmentation

Gene Therapy Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-Cell Lymphoma
- Melanoma (lesions)
- Beta-Thalassemia Major/SCD
- Spinal Muscular Atrophy (SMA)
- Others
Gene Therapy Route of Administration Outlook (Revenue, USD Million; 2018 - 2030)
- Intravenous
- Others
Gene Therapy Vector Type Outlook (Revenue, USD Million; 2018 - 2030)
- Lentivirus
- AAV
- RetroVirus & gamma RetroVirus
- Modified Herpes Simplex Virus
- Adenovirus
- Others
Gene Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Gene Therapy Market, by Indication
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Spinal Muscular Atrophy (SMA)
    - Others
  - North America Gene Therapy Market, by Vector Type
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - North America Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - U.S.
    - U.S. Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - U.S. Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - U.S. Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - Canada
    - Canada Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Canada Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - Canada Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
- Europe
  - Europe Gene Therapy Market, by Indication
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Spinal Muscular Atrophy (SMA)
    - Others
  - Europe Gene Therapy Market, by Vector Type
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - Europe Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - Germany
    - Germany Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Germany Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - Germany Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - UK
    - UK Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - UK Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - UK Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - Switzerland
    - Switzerland Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Switzerland Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - Switzerland Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
- Asia Pacific
  - Asia Pacific Gene Therapy Market, by Indication
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Spinal Muscular Atrophy (SMA)
    - Others
  - Asia Pacific Gene Therapy Market, by Vector Type
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - Asia Pacific Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - China
    - China Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - China Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - China Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - Japan
    - Japan Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Japan Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - Japan Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - Australia
    - Australia Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Australia Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - Australia Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
  - South Korea
    - South Korea Gene Therapy Market, by Indication
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Spinal Muscular Atrophy (SMA)
      - Others
    - South Korea Gene Therapy Market, by Vector Type
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
    - South Korea Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments